FDA Inspection
Gabriel Perez Lasala, MDGabriel Perez Lasala, MD – FDA Inspection, Mar 31, 2011
Record Details
This FDA Inspection record concerns Gabriel Perez Lasala, MD, with an inspection on March 31, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Gabriel Perez Lasala, MD
- Inspection Date
- March 31, 2011
- Product Type
- Biologics
View Company Profile
ID · 21bf60d3-667e-4aa3-9240-90d1ec37f17a
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 723216
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
5- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.61Unauthorized recipients (investigator)
- 21 CFR 312.66Initial and continuing review
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 50.20Consent not obtained, exceptions do not apply
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.